Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 9:
Gain Therapeutics, Inc. GANX: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Gain Therapeutics, Inc. Price and Consensus
Gain Therapeutics, Inc. price-consensus-chart | Gain Therapeutics, Inc. Quote
Gain Therapeutics' shares gained 23.9% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
Gain Therapeutics, Inc. Price
Gain Therapeutics, Inc. price | Gain Therapeutics, Inc. Quote
First Hawaiian, Inc. FHB: This bank holding company for First Hawaiian Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
First Hawaiian, Inc. Price and Consensus
First Hawaiian, Inc. price-consensus-chart | First Hawaiian, Inc. Quote
First Hawaiian's shares gained 10.5% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of A.
First Hawaiian, Inc. Price
First Hawaiian, Inc. price | First Hawaiian, Inc. Quote
The Travelers Companies, Inc. TRV: This insurance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
The Travelers Companies, Inc. Price and Consensus
The Travelers Companies, Inc. price-consensus-chart | The Travelers Companies, Inc. Quote
The Travelers Companies' shares gained 4.6% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
The Travelers Companies, Inc. Price
The Travelers Companies, Inc. price | The Travelers Companies, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Just Released: Zacks Top 10 Stocks for 2025
Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential.
The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report
First Hawaiian, Inc. (FHB) : Free Stock Analysis Report
Gain Therapeutics, Inc. (GANX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
